| Gene symbol | ANGPTL3 | Synonyms | ANG-5, ANGPT5, ANL3, FHBL2 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p31.3 | dbXrefs | |
| Description | angiopoietin like 3 | ||||
| GTO ID | GTC3899 |
| Trial ID | NCT06451770 |
| Disease | Hypercholesterolemia |
| Altered gene | ANGPTL3 |
| Therapeutic/Target gene | Target gene |
| Therapy | Gene editing |
| Treatment | VERVE-201 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase 1b Single Ascending Dose Study to Evaluate the Safety of VERVE-201 in Patients With Refractory Hyperlipidemia |
| Year | 2024 |
| Country | United States |
| Company sponsor | Verve Therapeutics, Inc. |
| Other ID(s) | VT-20101 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||